Cardiatis completes stent trial recruitment
Interventional device developer Cardiatis of Brussels, Belgium, has completed recruitment of patients into its first-in-man European clinical trial of its FluidSmart 3D multilayer braided stent for repairing aneurysms.
Patient recruitment, which began in December last year, culminates four years of extensive concept testing that demonstrated the ability of the 3D multilayer stent to repair aneurysms endovascularly without the need for coils or stent grafts, Cardiatis said.
The company said it anticipates filing for a CE Mark on the device by the end of this year.
Patient recruitment, which began in December last year, culminates four years of extensive concept testing that demonstrated the ability of the 3D multilayer stent to repair aneurysms endovascularly without the need for coils or stent grafts, Cardiatis said.
The company said it anticipates filing for a CE Mark on the device by the end of this year.